MLXIPL and colorectal cancer: We have reported that AGEs promoted ChREBP expression and activity in colorectal cancer cells.[15] Similarly, we investigated whether AGEs changed ChREBP expression in HepG2 cells by treating cells with different concentration of glucose conditions supplemented with either AGEs or BSA for 24 hours.